Arix Bioscience Management
Management criteria checks 2/4
Arix Bioscience's CEO is Rob Lyne, appointed in Apr 2021, has a tenure of 2.67 years. total yearly compensation is £701.00K, comprised of 42.8% salary and 57.2% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth £225.31K. The average tenure of the management team and the board of directors is 0.8 years and 2.7 years respectively.
Key information
Rob Lyne
Chief executive officer
UK£701.0k
Total compensation
| CEO salary percentage | 42.8% |
| CEO tenure | 2.7yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | UK£15m |
| Mar 31 2023 | n/a | n/a | -UK£6m |
| Dec 31 2022 | UK£701k | UK£300k | -UK£28m |
| Sep 30 2022 | n/a | n/a | -UK£40m |
| Jun 30 2022 | n/a | n/a | -UK£53m |
| Mar 31 2022 | n/a | n/a | -UK£57m |
| Dec 31 2021 | UK£442k | UK£188k | -UK£61m |
Compensation vs Market: Rob's total compensation ($USD881.57K) is about average for companies of similar size in the UK market ($USD745.86K).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Lyne (40 yo)
2.7yrs
Tenure
UK£701,000
Compensation
Mr. Robert Lyne, also known as Rob, is Chief Executive Officer of Arix Bioscience plc from June 2022 and serves as its Director since August 2022 and served as its General Counsel. Mr. Lyne previously serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | UK£701.00k | 0.16% £ 225.3k | |
| Finance Director | less than a year | no data | no data | |
| Investor Relations Officer | less than a year | no data | no data | |
| Managing Director | less than a year | no data | no data | |
| Financial Controller | less than a year | no data | no data | |
| Associate | no data | no data | no data | |
| Analyst | no data | no data | no data |
0.8yrs
Average Tenure
Experienced Management: ARIXL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | UK£701.00k | 0.16% £ 225.3k | |
| Non-Executive Director | 2.7yrs | UK£85.00k | no data | |
| Non-Executive Director | 2.7yrs | UK£85.00k | no data | |
| Independent Non-Executive Chairman | 2.7yrs | UK£150.00k | 0.58% £ 821.5k | |
| Independent Non-Executive Director | 1.3yrs | UK£33.00k | no data | |
| Senior Independent Director | 1.3yrs | UK£38.00k | 0.040% £ 57.1k |
2.7yrs
Average Tenure
61yo
Average Age
Experienced Board: ARIXL's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/12 09:09 |
| End of Day Share Price | 2023/09/14 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arix Bioscience plc is covered by 9 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Maxim Jacobs | Edison Investment Research |
| Yingheng Chen | Hardman & Co. |
| Dorothea Hill | Hardman & Co. |